{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:58:57Z","timestamp":1793465937521,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03875-2","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:48:35Z","timestamp":1749815315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of serum lipids on prognosis in breast cancer patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Wendong","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hegen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"issue":"3","key":"3875_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3875_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaoncol.2018.5327","volume":"5","author":"NM Iyengar","year":"2019","unstructured":"Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, et al. Association of body fat and risk of breast Cancer in postmenopausal women with normal body mass index: A secondary analysis of a randomized clinical trial and observational study. JAMA Oncol. 2019;5(2):155\u201363. https:\/\/doi.org\/10.1001\/jamaoncol.2018.5327.","journal-title":"JAMA Oncol"},{"issue":"1","key":"3875_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/jco.2010.29.7614","volume":"29","author":"M Ewertz","year":"2011","unstructured":"Ewertz M, Jensen MB, Gunnarsd\u00f3ttir K, H\u00f8jris I, Jakobsen EH, Nielsen D, et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol. 2011;29(1):25\u201331. https:\/\/doi.org\/10.1200\/jco.2010.29.7614.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3875_CR4","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1016\/j.jacl.2024.04.001","volume":"18","author":"HE Bays","year":"2024","unstructured":"Bays HE, Kirkpatrick CF, Maki KC, Toth PP, Morgan RT, Tondt J, et al. Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the obesity medicine association and the National lipid association 2024. J Clin Lipidol. 2024;18(3):e320\u201350. https:\/\/doi.org\/10.1016\/j.jacl.2024.04.001.","journal-title":"J Clin Lipidol"},{"key":"3875_CR5","doi-asserted-by":"publisher","unstructured":"Murawska K, Krintus M, Kuligowska-Prusinska M, Szternel L, Stefanska A, Sypniewska G. Relationship between serum Angiopoietin-like proteins 3 and 8 and atherogenic lipid biomarkers in Non-Diabetic adults depends on gender and obesity. Nutrients. 2021;13(12). https:\/\/doi.org\/10.3390\/nu13124339.","DOI":"10.3390\/nu13124339"},{"issue":"25 Suppl 2","key":"3875_CR6","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"MD Jensen","year":"2014","unstructured":"Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American college of cardiology\/american heart association task force on practice guidelines and the obesity society. Circulation. 2014;129(25 Suppl 2):S102\u201338. https:\/\/doi.org\/10.1161\/01.cir.0000437739.71477.ee.","journal-title":"Circulation"},{"key":"3875_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphar.2013.00119","volume":"4","author":"PM Cruz","year":"2013","unstructured":"Cruz PM, Mo H, McConathy WJ, Sabnis N, Lacko AG. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 2013;4:119. https:\/\/doi.org\/10.3389\/fphar.2013.00119.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3875_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0009-9120(00)00200-9","volume":"34","author":"G Ray","year":"2001","unstructured":"Ray G, Husain SA. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem. 2001;34(1):71\u20136. https:\/\/doi.org\/10.1016\/s0009-9120(00)00200-9.","journal-title":"Clin Biochem"},{"issue":"1","key":"3875_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clnu.2004.08.004","volume":"24","author":"E Esteve","year":"2005","unstructured":"Esteve E, Ricart W, Fern\u00e1ndez-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr. 2005;24(1):16\u201331. https:\/\/doi.org\/10.1016\/j.clnu.2004.08.004.","journal-title":"Clin Nutr"},{"issue":"2","key":"3875_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10549-004-3607-7","volume":"90","author":"U Langsenlehner","year":"2005","unstructured":"Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, K\u00f6ppel H, et al. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2005;90(2):113\u20135. https:\/\/doi.org\/10.1007\/s10549-004-3607-7.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3875_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10549-018-5056-8","volume":"174","author":"DT Dibaba","year":"2019","unstructured":"Dibaba DT, Ogunsina K, Braithwaite D, Akinyemiju T. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype. Breast Cancer Res Treat. 2019;174(1):209\u201318. https:\/\/doi.org\/10.1007\/s10549-018-5056-8.","journal-title":"Breast Cancer Res Treat"},{"key":"3875_CR12","doi-asserted-by":"publisher","first-page":"175883592311770","DOI":"10.1177\/17588359231177004","volume":"15","author":"S Dong","year":"2023","unstructured":"Dong S, Yu J, Chen X, Shen K. Association of serum lipid levels and clinical outcomes in early breast cancer patients. Ther Adv Med Oncol. 2023;15:17588359231177004. https:\/\/doi.org\/10.1177\/17588359231177004.","journal-title":"Ther Adv Med Oncol"},{"key":"3875_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1471-2407-14-132","volume":"14","author":"C Rodrigues Dos Santos","year":"2014","unstructured":"Rodrigues Dos Santos C, Fonseca I, Dias S, Mendes de Almeida JC. Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC Cancer. 2014;14:132. https:\/\/doi.org\/10.1186\/1471-2407-14-132.","journal-title":"BMC Cancer"},{"issue":"2","key":"3875_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-005-6654-9","volume":"94","author":"M Bahl","year":"2005","unstructured":"Bahl M, Ennis M, Tannock IF, Hux JE, Pritchard KI, Koo J, et al. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res Treat. 2005;94(2):135\u201344. https:\/\/doi.org\/10.1007\/s10549-005-6654-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3875_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10552-016-0832-4","volume":"28","author":"M His","year":"2017","unstructured":"His M, Dartois L, Fagherazzi G, Boutten A, Dupr\u00e9 T, Mesrine S, et al. Associations between serum lipids and breast cancer incidence and survival in the E3N prospective cohort study. Cancer Causes Control. 2017;28(1):77\u201388. https:\/\/doi.org\/10.1007\/s10552-016-0832-4.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"3875_CR16","first-page":"e123","volume":"3","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3(3):e123\u201330.","journal-title":"Open Med"},{"issue":"9","key":"3875_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"3875_CR18","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.5301\/jbm.5000143","volume":"30","author":"Y Fan","year":"2015","unstructured":"Fan Y, Ding X, Wang J, Ma F, Yuan P, Li Q, et al. Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast cancer but not non-TNBCs. Int J Biol Markers. 2015;30(2):e200\u20137. https:\/\/doi.org\/10.5301\/jbm.5000143.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"3875_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40001-022-00964-w","volume":"28","author":"W Goto","year":"2023","unstructured":"Goto W, Kashiwagi S, Takada K, Asano Y, Ogisawa K, Morisaki T, et al. Clinical verification of the relationship between serum lipid metabolism and immune activity in breast cancer patients treated with neoadjuvant chemotherapy. Eur J Med Res. 2023;28(1):2. https:\/\/doi.org\/10.1186\/s40001-022-00964-w.","journal-title":"Eur J Med Res"},{"issue":"1","key":"3875_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12885-023-10683-y","volume":"23","author":"Y Ma","year":"2023","unstructured":"Ma Y, Lv M, Yuan P, Chen X, Liu Z. Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy. BMC Cancer. 2023;23(1):208. https:\/\/doi.org\/10.1186\/s12885-023-10683-y.","journal-title":"BMC Cancer"},{"issue":"5","key":"3875_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1159\/000531943","volume":"18","author":"N AiErken","year":"2023","unstructured":"AiErken N, Shao N, Liu Y, Shi H, Shi Y, Yuan Z, et al. Effect of lipid levels on Tumor-Infiltrating lymphocytes and prognosis in patients with Triple-Negative breast Cancer. Breast Care (Basel). 2023;18(5):390\u20138. https:\/\/doi.org\/10.1159\/000531943.","journal-title":"Breast Care (Basel)"},{"issue":"13","key":"3875_CR22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1097\/cm9.0000000000001988","volume":"135","author":"P Yang","year":"2022","unstructured":"Yang P, He Y, Yu X, Liu B, Wang X, Li X, et al. Impact of body mass index, weight gain, and metabolic disorders on survival and prognosis in patients with breast cancer who underwent chemotherapy. Chin Med J (Engl). 2022;135(13):1555\u201362. https:\/\/doi.org\/10.1097\/cm9.0000000000001988.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"3875_CR23","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1212\/wnl.37.10.1688","volume":"37","author":"DB Smith","year":"1987","unstructured":"Smith DB, Alvarez R. Progressive bulbar palsy and gammopathy. Neurology. 1987;37(10):1688\u20139. https:\/\/doi.org\/10.1212\/wnl.37.10.1688.","journal-title":"Neurology"},{"issue":"2","key":"3875_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-020-05701-7","volume":"182","author":"G Buono","year":"2020","unstructured":"Buono G, Crispo A, Giuliano M, De Angelis C, Schettini F, Forestieri V, et al. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study. Breast Cancer Res Treat. 2020;182(2):401\u20139. https:\/\/doi.org\/10.1007\/s10549-020-05701-7.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3875_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10549-020-06034-1","volume":"186","author":"K Kennard","year":"2021","unstructured":"Kennard K, Buckley ME, Sizer LM, Larson S, Carter WB, Frazier TG, et al. Metabolic syndrome: does this influence breast cancer outcomes in the triple-negative population? Breast Cancer Res Treat. 2021;186(1):53\u201363. https:\/\/doi.org\/10.1007\/s10549-020-06034-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"3875_CR26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.7150\/jca.15776","volume":"7","author":"D Dai","year":"2016","unstructured":"Dai D, Chen B, Wang B, Tang H, Li X, Zhao Z, et al. Pretreatment TG\/HDL-C ratio is superior to triacylglycerol level as an independent prognostic factor for the survival of triple negative breast Cancer patients. J Cancer. 2016;7(12):1747\u201354. https:\/\/doi.org\/10.7150\/jca.15776.","journal-title":"J Cancer"},{"issue":"1","key":"3875_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12885-022-09234-8","volume":"22","author":"W Goto","year":"2022","unstructured":"Goto W, Kashiwagi S, Kamei Y, Watanabe C, Aomatsu N, Ikeda K, et al. Relationship between serum lipid levels and the immune microenvironment in breast cancer patients: a retrospective study. BMC Cancer. 2022;22(1):167. https:\/\/doi.org\/10.1186\/s12885-022-09234-8.","journal-title":"BMC Cancer"},{"issue":"7","key":"3875_CR28","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/his.14081","volume":"76","author":"T Jankovic-Karasoulos","year":"2020","unstructured":"Jankovic-Karasoulos T, Bianco-Miotto T, Butler MS, Butler LM, McNeil CM, O\u2019Toole SA, et al. Elevated levels of tumour Apolipoprotein D independently predict poor outcome in breast cancer patients. Histopathology. 2020;76(7):976\u201387. https:\/\/doi.org\/10.1111\/his.14081.","journal-title":"Histopathology"},{"key":"3875_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5453-8","author":"X Xu","year":"2016","unstructured":"Xu X, Wan J, Yuan L, Ba J, Feng P, Long W, et al. Serum levels of Apolipoprotein E correlates with disease progression and poor prognosis in breast cancer. Tumour Biol. 2016. https:\/\/doi.org\/10.1007\/s13277-016-5453-8.","journal-title":"Tumour Biol"},{"issue":"5","key":"3875_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0277-5379(91)90234-5","volume":"27","author":"LJ Vatten","year":"1991","unstructured":"Vatten LJ, Foss OP, Kvinnsland S. Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur J Cancer. 1991;27(5):641\u20136. https:\/\/doi.org\/10.1016\/0277-5379(91)90234-5.","journal-title":"Eur J Cancer"},{"key":"3875_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2016.11.024","volume":"32","author":"X Li","year":"2017","unstructured":"Li X, Tang H, Wang J, Xie X, Liu P, Kong Y, et al. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer. Breast. 2017;32:1\u20136. https:\/\/doi.org\/10.1016\/j.breast.2016.11.024.","journal-title":"Breast"},{"key":"3875_CR32","doi-asserted-by":"publisher","first-page":"629666","DOI":"10.3389\/fonc.2021.629666","volume":"11","author":"S Dong","year":"2021","unstructured":"Dong S, Wang Z, Shen K, Chen X. Metabolic syndrome and breast cancer: prevalence, treatment response, and prognosis. Front Oncol. 2021;11:629666. https:\/\/doi.org\/10.3389\/fonc.2021.629666.","journal-title":"Front Oncol"},{"issue":"1","key":"3875_CR33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1186\/s12885-022-10430-9","volume":"22","author":"AS Zimbalist","year":"2022","unstructured":"Zimbalist AS, Caan BJ, Chen WY, Mittendorf EA, Dillon DAR, Quesenberry C, et al. Metabolic abnormalities and survival among patients with non-metastatic breast cancer. BMC Cancer. 2022;22(1):1361. https:\/\/doi.org\/10.1186\/s12885-022-10430-9.","journal-title":"BMC Cancer"},{"key":"3875_CR34","unstructured":"Introduction to Meta-Analysis. [Available from: https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9780470743386.fmatter"},{"key":"3875_CR35","doi-asserted-by":"publisher","unstructured":"Park M, Kim D, Ko S, Kim A, Mo K, Yoon H. Breast Cancer metastasis: mechanisms and therapeutic implications. Int J Mol Sci. 2022;23(12). https:\/\/doi.org\/10.3390\/ijms23126806.","DOI":"10.3390\/ijms23126806"},{"issue":"7","key":"3875_CR36","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1002\/jcp.27802","volume":"234","author":"D Ge","year":"2019","unstructured":"Ge D, Gao J, Han L, Li Y, Liu HH, Yang WC, et al. Novel effects of sphingosylphosphorylcholine on the apoptosis of breast cancer via autophagy\/AKT\/p38 and JNK signaling. J Cell Physiol. 2019;234(7):11451\u201362. https:\/\/doi.org\/10.1002\/jcp.27802.","journal-title":"J Cell Physiol"},{"issue":"5","key":"3875_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/09637486.2017.1401980","volume":"69","author":"A Filippi","year":"2018","unstructured":"Filippi A, Picot T, Aanei CM, Nagy P, Sz\u00f6ll\u0151si J, Campos L, et al. Epigallocatechin-3-O-gallate alleviates the malignant phenotype in A-431 epidermoid and SK-BR-3 breast cancer cell lines. Int J Food Sci Nutr. 2018;69(5):584\u201397. https:\/\/doi.org\/10.1080\/09637486.2017.1401980.","journal-title":"Int J Food Sci Nutr"},{"issue":"1","key":"3875_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12944-019-1075-7","volume":"18","author":"X Guan","year":"2019","unstructured":"Guan X, Liu Z, Zhao Z, Zhang X, Tao S, Yuan B, et al. Emerging roles of low-density lipoprotein in the development and treatment of breast cancer. Lipids Health Dis. 2019;18(1):137. https:\/\/doi.org\/10.1186\/s12944-019-1075-7.","journal-title":"Lipids Health Dis"},{"key":"3875_CR39","doi-asserted-by":"publisher","unstructured":"Ced\u00f3 L, Reddy ST, Mato E, Blanco-Vaca F, Escol\u00e0-Gil JC. HDL and LDL: potential new players in breast Cancer development. J Clin Med. 2019;8(6). https:\/\/doi.org\/10.3390\/jcm8060853.","DOI":"10.3390\/jcm8060853"},{"issue":"11","key":"3875_CR40","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s12094-020-02354-2","volume":"22","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Luo G. Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer. Clin Transl Oncol. 2020;22(11):1952\u201362. https:\/\/doi.org\/10.1007\/s12094-020-02354-2.","journal-title":"Clin Transl Oncol"},{"key":"3875_CR41","doi-asserted-by":"publisher","first-page":"15959","DOI":"10.1007\/s13277-016-5453-8","volume":"37","author":"X Xu","year":"2016","unstructured":"Xu X, Wan J, Yuan L, Ba J, Feng P, Long W, et al. Serum levels of Apolipoprotein E correlates with disease progression and poor prognosis in breast cancer. Tumour Biol. 2016;37:15959\u201366. https:\/\/doi.org\/10.1007\/s13277-016-5453-8.","journal-title":"Tumour Biol"},{"issue":"33","key":"3875_CR42","doi-asserted-by":"publisher","first-page":"e21498","DOI":"10.1097\/md.0000000000021498","volume":"99","author":"T He","year":"2020","unstructured":"He T, Wang C, Tan Q, Wang Z, Li J, Chen T, et al. Adjuvant chemotherapy-associated lipid changes in breast cancer patients: A real-word retrospective analysis. Med (Baltim). 2020;99(33):e21498. https:\/\/doi.org\/10.1097\/md.0000000000021498.","journal-title":"Med (Baltim)"},{"issue":"11","key":"3875_CR43","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.7150\/jca.18743","volume":"8","author":"SF Shaitelman","year":"2017","unstructured":"Shaitelman SF, Stauder MC, Allen P, Reddy S, Lakoski S, Atkinson B, et al. Impact of Statin use on outcomes in triple negative breast Cancer. J Cancer. 2017;8(11):2026\u201332. https:\/\/doi.org\/10.7150\/jca.18743.","journal-title":"J Cancer"},{"key":"3875_CR44","doi-asserted-by":"publisher","unstructured":"Kim HY, Bae SJ, Choi JW, Han S, Bae SH, Cheong JH, et al. Cholesterol synthesis is important for breast Cancer cell tumor sphere formation and invasion. Biomedicines. 2022;10(8). https:\/\/doi.org\/10.3390\/biomedicines10081908.","DOI":"10.3390\/biomedicines10081908"},{"issue":"1","key":"3875_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2007.10.002.","journal-title":"Cell Metab"},{"issue":"34","key":"3875_CR46","doi-asserted-by":"publisher","first-page":"15051","DOI":"10.1073\/pnas.0910258107","volume":"107","author":"JW Clendening","year":"2010","unstructured":"Clendening JW, Pandyra A, Boutros PC, El Ghamrasni S, Khosravi F, Trentin GA, et al. Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci U S A. 2010;107(34):15051\u20136. https:\/\/doi.org\/10.1073\/pnas.0910258107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3875_CR47","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/stem.1122","volume":"30","author":"C Ginestier","year":"2012","unstructured":"Ginestier C, Monville F, Wicinski J, Cabaud O, Cervera N, Josselin E, et al. Mevalonate metabolism regulates basal breast cancer stem cells and is a potential therapeutic target. Stem Cells. 2012;30(7):1327\u201337. https:\/\/doi.org\/10.1002\/stem.1122.","journal-title":"Stem Cells"},{"issue":"1","key":"3875_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","volume":"178","author":"G Llaverias","year":"2011","unstructured":"Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, et al. Role of cholesterol in the development and progression of breast cancer. Am J Pathol. 2011;178(1):402\u201312. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.005.","journal-title":"Am J Pathol"},{"issue":"1","key":"3875_CR49","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12885-018-4568-2","volume":"18","author":"T Lofter\u00f8d","year":"2018","unstructured":"Lofter\u00f8d T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, et al. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. 2018;18(1):654. https:\/\/doi.org\/10.1186\/s12885-018-4568-2.","journal-title":"BMC Cancer"},{"issue":"8","key":"3875_CR50","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1097\/js9.0000000000001582","volume":"110","author":"L Li","year":"2024","unstructured":"Li L, Wang H, Zhang S, Gao S, Lu X, Pan Y, et al. Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8\u2009+\u2009T cytotoxicity for better prognosis in breast cancer. Int J Surg. 2024;110(8):4716\u201326. https:\/\/doi.org\/10.1097\/js9.0000000000001582.","journal-title":"Int J Surg"},{"key":"3875_CR51","doi-asserted-by":"publisher","first-page":"175456","DOI":"10.1016\/j.ejphar.2022.175456","volume":"939","author":"JV Jovanki\u0107","year":"2023","unstructured":"Jovanki\u0107 JV, Nikodijevi\u0107 DD, Milutinovi\u0107 MG, Nikezi\u0107 AG, Koji\u0107 VV, Cvetkovi\u0107 AM, et al. Potential of Orlistat to induce apoptotic and antiangiogenic effects as well as Inhibition of fatty acid synthesis in breast cancer cells. Eur J Pharmacol. 2023;939:175456. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175456.","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"3875_CR52","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.21873\/anticanres.12083","volume":"37","author":"E Sokolowska","year":"2017","unstructured":"Sokolowska E, Presler M, Goyke E, Milczarek R, Swierczynski J, Sledzinski T. Orlistat reduces proliferation and enhances apoptosis in human pancreatic Cancer cells (PANC-1). Anticancer Res. 2017;37(11):6321\u20137. https:\/\/doi.org\/10.21873\/anticanres.12083.","journal-title":"Anticancer Res"},{"issue":"1","key":"3875_CR53","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1038\/s41598-021-84538-6","volume":"11","author":"A Schcolnik-Cabrera","year":"2021","unstructured":"Schcolnik-Cabrera A, Chavez-Blanco A, Dominguez-Gomez G, Juarez M, Vargas-Castillo A, Ponce-Toledo RI, et al. Pharmacological Inhibition of tumor anabolism and host catabolism as a cancer therapy. Sci Rep. 2021;11(1):5222. https:\/\/doi.org\/10.1038\/s41598-021-84538-6.","journal-title":"Sci Rep"},{"issue":"1","key":"3875_CR54","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s42003-021-02710-0","volume":"4","author":"N Giallourou","year":"2021","unstructured":"Giallourou N, Urbaniak C, Puebla-Barragan S, Vorkas PA, Swann JR, Reid G. Characterizing the breast cancer lipidome and its interaction with the tissue microbiota. Commun Biol. 2021;4(1):1229. https:\/\/doi.org\/10.1038\/s42003-021-02710-0.","journal-title":"Commun Biol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03875-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03875-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03875-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:48:37Z","timestamp":1749815317000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03875-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3875"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03875-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Potential conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"234"}}